PPD, Inc. PPD
47.28 0.00 (+0.00%)
Apr 24, 2025, 3:47 PM EDT
47.24 Day range 47.40
52-week range unavailable
News
businesswire.com Thermo Fisher Scientific's PPD Clinical Research Business Expands Bioanalytical Capabilities with New Laboratory in Gothenburg, Sweden WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced the opening of a new bioanalytical and biomarker laboratory in Gothenburg, Sweden,…
businesswire.com Thermo Fisher Scientific's PPD Clinical Research Business Collaborates with HealthVerity to Expand Real-World Data Capabilities WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced a strategic data collaboration with HealthVerity, a leading real-world data (RWD)…
prnewswire.com Lipocine Announces Last Patient Last Visit in Pivotal Phase 3 Trial of LPCN 1154 for Postpartum Depression (PPD) SALT LAKE CITY, Feb. 18, 2026 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to develop innovative products with effective…
prnewswire.com Lipocine Announces Completion of Enrollment and Dosing in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD) SALT LAKE CITY, Jan. 20, 2026 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to develop innovative products with effective…
prnewswire.com Lipocine Reports Encouraging Progress Post Second Interim Safety Review in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD) Company on track to report topline results early in the second quarter of 2026 Second planned Data and Safety Monitoring Board (DSMB) meeting evaluated all available safety data for the 82 randomized…
businesswire.com Thermo Fisher Scientific Launches PPD CorEvitas Alzheimer's Disease Registry to Advance Real-World Evidence in Neurodegenerative Care WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Launches PPD CorEvitas Alzheimer's Disease Registry to Advance Real-World Evidence in Neurodegenerative Care.
prnewswire.com Lipocine Highlights Promising Interim Safety Profile in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD) Per the Drug Safety Monitoring Board (DSMB) meeting evaluating one-third of planned participants, study to continue as planned More than half of planned participants have completed dosing with no…
prnewswire.com Lipocine Provides Progress Update on LPCN 1154 Phase 3 Clinical Trial in Postpartum Depression (PPD) One-Third of Patients Randomized; Topline Results Expected in 2Q 2026 DSMB Safety Review Update Planned for 4Q 2025 SALT LAKE CITY , Sept. 30, 2025 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a…
globenewswire.com Reunion Neuroscience Announces Positive Topline Results from RECONNECT Phase 2 Clinical Trial of RE104 for the Treatment of Postpartum Depression (PPD) -- Achieved Primary Endpoint with 30mg Dose of RE104 Demonstrating 23.0-Point Reduction from Baseline in Montgomery-Åsberg Depression Rating Scale (MADRS) Score on Day 7, a 5.8-Point Greater…
globenewswire.com Reunion Neuroscience Announces Last Patient Dosed in RECONNECT Phase 2 Clinical Trial of RE104 for the Treatment of Postpartum Depression (PPD) -- Enrollment Completed on Schedule; Topline Results Expected Q3 2025 -- -- Company to Present Poster Reviewing RE104 Phase 1 Results at the American Society of Clinical Psychopharmacology (ASCP)…
accesswire.com FINAL PPD DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds PDD Holdings Inc. f/k/a Pinduoduo Inc. Investors to Join the Class Action Lawsuit! NEW YORK, NY / ACCESSWIRE / October 15, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against PDD Holdings…
businesswire.com ZURZUVAE™ (zuranolone) CIV, a Landmark Oral Treatment for Women with Postpartum Depression (PPD), is Now Available in the U.S. CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics, Inc. (Nasdaq: SAGE) and Biogen Inc. (Nasdaq: BIIB) announced ZURZUVAE™ (zuranolone) 50 mg (two 25 mg capsules per day) CIV is now available by…
headlinesoftoday.com Brii Biosciences Provides Corporate Update and Reports Full-Year 2022 Financial Results Company maintains priority focus on clinical programs to develop a novel functional cure for hepatitis B viral (HBV) infection and a potential first-of-its-kind treatment for postpartum depression…
businesswire.com Thermo Fisher Scientific's PPD Clinical Research Business Earns TOPRA Award for Regulatory Affairs Excellence in Supporting Novavax's COVID-19 Vaccine Approval WILMINGTON, N.C.--(BUSINESS WIRE)--The clinical research business of Thermo Fisher Scientific has won a 2021 TOPRA Award for Regulatory Excellence.
businesswire.com Saama Appoints Scott Rogers as Company's Chief Financial Officer CAMPBELL, Calif.--(BUSINESS WIRE)-- #AI--Veteran finance executive Scott Rogers appointed Saama CFO following recent $430 million dollar growth investment announcement
prnewswire.com Thermo Fisher Scientific Completes Acquisition of PPD, Inc. WALTHAM, Mass., Dec. 8, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed its acquisition of PPD, Inc.…
businesswire.com PPD Named to ‘Best Workplaces in Greater China’ for Second Consecutive Year WILMINGTON, N.C.--(BUSINESS WIRE)--PPD, Inc. (Nasdaq: PPD) was named one of the “Best Workplaces in Greater China™ 2021” by Great Place to Work® for successfully creating an inclusive workplace…
businesswire.com PPD Named to ‘Best Workplaces in Greater China' for Second Consecutive Year WILMINGTON, N.C.--(BUSINESS WIRE)--PPD was named one of the “Best Workplaces in Greater China™ 2021” by Great Place to Work® for successfully creating an inclusive workplace experience.
businesswire.com PPD 连续第二年荣膺2021年度“大中华区最佳职场TM”称号 北卡罗来纳州威明顿--(BUSINESS WIRE)--PPD, Inc.（纳斯达克代码：PPD）被卓越职场（®Great Place to Work®）评为“ 2021年度大中华区最佳职场™ ”（Best Workplaces in Greater China™），这都归功于PPD为员工创造了包容性的职场体验。…
benzinga.com Earnings Scheduled For October 27, 2021 Companies Reporting Before The Bell • McDonald's (NYSE:MCD) is expected to report quarterly earnings at $2.46 per share on revenue of $6.03 billion.
benzinga.com Earnings Scheduled For July 28, 2021 Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.55 per share on revenue of $7.90 billion.
benzinga.com Stocks That Hit 52-Week Highs On Monday During Monday's morning session, 255 companies made new 52-week highs.
benzinga.com Stocks That Hit 52-Week Highs On Wednesday During Wednesday's morning trading, 251 companies set new 52-week highs.
benzinga.com Earnings Scheduled For April 27, 2021 Companies Reporting Before The Bell • Camden National (NASDAQ:CAC) is projected to report quarterly earnings at $1.01 per share on revenue of $45.73 million.
benzinga.com Stocks That Hit 52-Week Highs On Monday Before 10 a.m. ET Monday, 197 stocks hit new 52-week highs.- benzinga.com Stocks That Hit 52-Week Highs On Friday Friday's morning session saw 420 companies set new 52-week highs.
benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For April 16, 2021 
benzinga.com Stocks That Hit 52-Week Highs On Thursday Thursday morning saw 166 companies set new 52-week highs.- benzinga.com Stocks That Hit 52-Week Highs On Monday Monday's morning session saw 277 companies set new 52-week highs.
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2021
- benzinga.com 52 Weeks High Article 0.004831689889895241 Stocks That Hit 52-Week Highs On Friday Before 10 a.m. ET on Friday, 202 companies set new 52-week highs.
- benzinga.com Earnings Scheduled For October 27, 2020 Companies Reporting Before The Bell • Camden National (NASDAQ:CAC) is estimated to report quarterly earnings at $0.81 per share on revenue of $45.90 million.
- benzinga.com 32 Stocks Moving in Tuesday's Pre-Market Session Gainers Novus Therapeutics, Inc. (NASDAQ: NVUS) rose 158.3% to $0.9790 in pre-market trading after the company reported the purchase of Anelixis Therapeutics.
- benzinga.com Stocks That Hit 52-Week Highs On Thursday This morning 92 companies reached new 52-week highs.
- benzinga.com Stocks That Hit 52-Week Highs On Wednesday This morning 103 companies reached new 52-week highs.
- benzinga.com Stocks That Hit 52-Week Highs On Tuesday During Tuesday's morning session, 78 stocks hit new 52-week highs.
- benzinga.com Stocks That Hit 52-Week Highs On Monday During Monday's morning session, 127 stocks hit new 52-week highs.
benzinga.com Benzinga's Top Upgrades, Downgrades For March 23, 2020 - benzinga.com Merger Arbitrage Mondays – July 4, 2011
benzinga.com Merger Arbitrage Mondays – July 4, 2011